148 related articles for article (PubMed ID: 34941552)
21. The IMPROVE-GAP Trial aiming to improve evidence-based management of community-acquired pneumonia: study protocol for a stepped-wedge randomised controlled trial.
Skinner EH; Lloyd M; Janus E; Ong ML; Karahalios A; Haines TP; Kelly AM; Shackell M; Karunajeewa H
Trials; 2018 Feb; 19(1):88. PubMed ID: 29402313
[TBL] [Abstract][Full Text] [Related]
22. Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs.
Hata T; Nakamura K; Yonemori K; Noguchi E; Watanabe M; Sohn J; Lu YS; Yap YS; Tamura K; Fujiwara Y
Clin Transl Sci; 2021 May; 14(3):1015-1025. PubMed ID: 33382914
[TBL] [Abstract][Full Text] [Related]
23. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
Rees CA; Pica N; Monuteaux MC; Bourgeois FT
PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
[TBL] [Abstract][Full Text] [Related]
24. Clinical trial metadata: defining and extracting metadata on the design, conduct, results and costs of 125 randomised clinical trials funded by the National Institute for Health Research Health Technology Assessment programme.
Raftery J; Young A; Stanton L; Milne R; Cook A; Turner D; Davidson P
Health Technol Assess; 2015 Feb; 19(11):1-138. PubMed ID: 25671821
[TBL] [Abstract][Full Text] [Related]
25. Lessons learned: Infrastructure development and financial management for large, publicly funded, international trials.
Larson GS; Carey C; Grarup J; Hudson F; Sachi K; Vjecha MJ; Gordin F;
Clin Trials; 2016 Apr; 13(2):127-36. PubMed ID: 26908541
[TBL] [Abstract][Full Text] [Related]
26. A critical analysis of neuro-oncology clinical trials.
Kim Y; Armstrong TS; Gilbert MR; Celiku O
Neuro Oncol; 2023 Sep; 25(9):1658-1671. PubMed ID: 36757281
[TBL] [Abstract][Full Text] [Related]
27. Coordination and management of multisite complementary and alternative medicine (CAM) therapies: experience from a multisite reflexology intervention trial.
Rahbar MH; Wyatt G; Sikorskii A; Victorson D; Ardjomand-Hessabi M
Contemp Clin Trials; 2011 Sep; 32(5):620-9. PubMed ID: 21664296
[TBL] [Abstract][Full Text] [Related]
28. Development and Validation of a Clinical Trial Accrual Predictive Regression Model at a Single NCI-Designated Comprehensive Cancer Center.
Tate WR; Cranmer LD
J Natl Compr Canc Netw; 2016 May; 14(5):561-9. PubMed ID: 27160234
[TBL] [Abstract][Full Text] [Related]
29. Assessing Genitourinary Cancer Clinical Trial Accrual Sufficiency Using Archived Trial Data.
Stensland K; Kaffenberger S; Canes D; Galsky M; Skolarus T; Moinzadeh A
JCO Clin Cancer Inform; 2020 Jul; 4():614-622. PubMed ID: 32667822
[TBL] [Abstract][Full Text] [Related]
30. Total versus partial knee replacement in patients with medial compartment knee osteoarthritis: the TOPKAT RCT.
Beard DJ; Davies LJ; Cook JA; MacLennan G; Price A; Kent S; Hudson J; Carr A; Leal J; Campbell H; Fitzpatrick R; Arden N; Murray D; Campbell MK
Health Technol Assess; 2020 Apr; 24(20):1-98. PubMed ID: 32369436
[TBL] [Abstract][Full Text] [Related]
31. Critical Care Network in the State of Qatar.
Hijjeh M; Al Shaikh L; Alinier G; Selwood D; Malmstrom F; Hassan IF
Qatar Med J; 2019; 2019(2):2. PubMed ID: 31763205
[TBL] [Abstract][Full Text] [Related]
32. Accrual monitoring in cardiovascular trials.
Baldi I; Gregori D; Desideri A; Berchialla P
Open Heart; 2017; 4(2):e000720. PubMed ID: 29344371
[TBL] [Abstract][Full Text] [Related]
33. Conducting clinical trials-costs, impacts, and the value of clinical trials networks: A scoping review.
Bentley C; Cressman S; van der Hoek K; Arts K; Dancey J; Peacock S
Clin Trials; 2019 Apr; 16(2):183-193. PubMed ID: 30628466
[TBL] [Abstract][Full Text] [Related]
34. Computable Phenotype Implementation for a National, Multicenter Pragmatic Clinical Trial: Lessons Learned From ADAPTABLE.
Ahmad FS; Ricket IM; Hammill BG; Eskenazi L; Robertson HR; Curtis LH; Dobi CD; Girotra S; Haynes K; Kizer JR; Kripalani S; Roe MT; Roumie CL; Waitman R; Jones WS; Weiner MG
Circ Cardiovasc Qual Outcomes; 2020 Jun; 13(6):e006292. PubMed ID: 32466729
[TBL] [Abstract][Full Text] [Related]
35. Using Bayesian hierarchical modeling for performance evaluation of clinical trial accrual for a cancer center.
Shi X; Mudaranthakam DP; Wick JA; Streeter D; Thompson JA; Streeter NR; Lin TL; Hines J; Mayo MS; Gajewski BJ
Contemp Clin Trials Commun; 2024 Apr; 38():101281. PubMed ID: 38419809
[TBL] [Abstract][Full Text] [Related]
36. Concept and implementation of a study dashboard module for a continuous monitoring of trial recruitment and documentation.
Toddenroth D; Sivagnanasundaram J; Prokosch HU; Ganslandt T
J Biomed Inform; 2016 Dec; 64():222-231. PubMed ID: 27769890
[TBL] [Abstract][Full Text] [Related]
37. Challenges to accrual predictions to phase III cancer clinical trials: a survey of study chairs and lead statisticians of 248 NCI-sponsored trials.
Schroen AT; Petroni GR; Wang H; Thielen MJ; Sargent D; Benedetti JK; Cronin WM; Wickerham DL; Wang XF; Gray R; Cohn WF; Slingluff CL; Djulbegovic B
Clin Trials; 2011 Oct; 8(5):591-600. PubMed ID: 21878447
[TBL] [Abstract][Full Text] [Related]
38. Gastrostomy versus nasogastric tube feeding for chemoradiation patients with head and neck cancer: the TUBE pilot RCT.
Paleri V; Patterson J; Rousseau N; Moloney E; Craig D; Tzelis D; Wilkinson N; Franks J; Hynes AM; Heaven B; Hamilton D; Guerrero-Urbano T; Donnelly R; Barclay S; Rapley T; Stocken D
Health Technol Assess; 2018 Apr; 22(16):1-144. PubMed ID: 29650060
[TBL] [Abstract][Full Text] [Related]
39. Variation in Accrual and Race/Ethnicity Reporting in Urological and Nonurological Related Cancer Trials.
Paul K; Sathianathen N; Dahm P; Le C; Konety BR
J Urol; 2019 Aug; 202(2):385-391. PubMed ID: 31074679
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
